- Home
- SGMO vs LFT Comparison
SGMO vs LFT Comparison
Compare SGMO & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- LFT
- Stock Information
- Founded
- SGMO 1995
- LFT 2012
- Country
- SGMO United States
- LFT United States
- Employees
- SGMO N/A
- LFT N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- LFT Real Estate Investment Trusts
- Sector
- SGMO Health Care
- LFT Real Estate
- Exchange
- SGMO Nasdaq
- LFT Nasdaq
- Market Cap
- SGMO 122.8M
- LFT 109.9M
- IPO Year
- SGMO 2000
- LFT N/A
- Fundamental
- Price
- SGMO $0.54
- LFT $2.16
- Analyst Decision
- SGMO Buy
- LFT Hold
- Analyst Count
- SGMO 6
- LFT 2
- Target Price
- SGMO $4.50
- LFT N/A
- AVG Volume (30 Days)
- SGMO 5.7M
- LFT 179.7K
- Earning Date
- SGMO 08-12-2025
- LFT 08-11-2025
- Dividend Yield
- SGMO N/A
- LFT 14.81%
- EPS Growth
- SGMO N/A
- LFT N/A
- EPS
- SGMO N/A
- LFT 0.20
- Revenue
- SGMO $63,756,000.00
- LFT $27,066,283.00
- Revenue This Year
- SGMO $1.29
- LFT $152.58
- Revenue Next Year
- SGMO $1.60
- LFT N/A
- P/E Ratio
- SGMO N/A
- LFT $10.85
- Revenue Growth
- SGMO 239.92
- LFT N/A
- 52 Week Low
- SGMO $0.41
- LFT $2.05
- 52 Week High
- SGMO $3.18
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- SGMO 50.80
- LFT 43.00
- Support Level
- SGMO $0.50
- LFT $2.19
- Resistance Level
- SGMO $0.70
- LFT $2.30
- Average True Range (ATR)
- SGMO 0.05
- LFT 0.08
- MACD
- SGMO 0.01
- LFT 0.01
- Stochastic Oscillator
- SGMO 29.17
- LFT 20.00
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.